Literature DB >> 7609366

[Results of posterior chamber lens implantation with trans-scleral sulcus suture fixation].

R Adam1, M Böhnke, F Körner.   

Abstract

BACKGROUND: Transscleral fixation of a posterior chamber intraocular lens has been proposed in eyes lacking adequate posterior capsular support.
METHODS: We performed a retrospective review of 38 eyes of 38 patients who had a 12 months follow-up. Visual acuity, intraocular pressure and complications have been studied. We performed a transscleral fixation of posterior chamber lens with the following indications: 1. planned intraocular cataract extraction; 2. following intraoperative complications of phacoemulsification; 3. in combination with perforating keratoplasty; 4. in combination with parsplana vitrectomy.
RESULTS: There were no serious intra- or shortly postoperative complications. 34% of the implanted lenses were not perfectly positioned. Up to 12 months, there were only minor problems in the anterior segment (suture erosions, anterior synechiae, iris capture). As longterm postoperative complications one patient developed retinal detachment, 3 others proliferative vitreoretinopathy after previous retinal detachment surgery. Two patients developed new onset glaucoma, and 3 glaucoma patients showed a medically uncontrollable intraocular pressure postoperatively.
CONCLUSIONS: The transscleral fixation of a posterior chamber intraocular lens has been performed in combination with a vitrectomy in order to minimize postoperative complications. Especially in combination with a pars-plana vitrectomy and silicone oil filing the transsclerally fixated posterior chamber intraocular lens is superior to the anterior chamber IOLs.

Entities:  

Mesh:

Year:  1995        PMID: 7609366     DOI: 10.1055/s-2008-1035442

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  1 in total

1.  Implantation of retropupillar iris claw lenses with and without combined penetrating keratoplasty.

Authors:  Florian Rüfer; Mark Saeger; Bernhard Nölle; Johann Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-12       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.